Nu-Haloperidol 0.5 mg Tablet is a Health Canada–registered human drug (DIN 02239216) held by Nu-Pharm Inc, containing Haloperidol. Health Canada lists its status as Cancelled (Unreturned Annual) (status date 28 Mar 2018). Nexara Health has matched 721 registrations of Haloperidol across 38 other regulated markets, 12 of them in the same strength and dosage form.
Health Canada registration
| DIN | 02239216 |
|---|---|
| Brand name | Nu-Haloperidol |
| Active ingredient | Haloperidol |
| Strength | 0.5 mg |
| Dosage form | Tablet |
| Route | Oral |
| Company | Nu-Pharm Inc |
| Status | Cancelled (Unreturned Annual) — 28 Mar 2018 |
| Class | Human |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Haloperidol registered in other markets
721 registrations of the same molecule in 38 national registries outside Canada (first 120 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Finland | Haloperin | Medipolar | 0.5 mg | tabletti | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Malta | Haloperidol 0.5mg Tablets | Crescent Pharma International Limited | Tablet | Authorised | Medicines Authority | |
| Malta | Haloperidol Laropharm 0.5 mg tablets | Farmarosib SRL | Tablet | Authorised | Medicines Authority | |
| Romania | HALOPERIDOL LAROPHARM 0,5 mg | — | 0,5mg | Compr. | PRF | ANMDMR nomenclator |
| Taiwan | Haldol Tablets 0.5 mg (Haloperidol) | 杏輝藥品工業股份有限公司 | 錠劑 | 已註銷 | TFDA | |
| Taiwan | Haldol Tablets 0.5mg | Interphil Laboratories Inc. For Janssen Pharmaceutica N.v. | 錠劑 | 已註銷 | TFDA | |
| Taiwan | Halin Tablets 0.5mg (Haloperidol) "Kojar" | 國嘉製藥工業股份有限公司 | 錠劑 | 已註銷 | TFDA | |
| Taiwan | Haloperidol 0.5mg Tablets | Industria Farmaceutica Iema S. A. S. | 錠劑 | 已註銷 | TFDA | |
| Taiwan | Haloperidol Tablets 0.5mg "T.t.y." | 臺灣東洋藥品工業股份有限公司中壢廠 | 錠劑 | 已註銷 | TFDA | |
| Taiwan | Haloperidol Tablets 0.5mg (Haloperidol) "Hamburg" | 漢堡製藥廠股份有限公司 | 錠劑 | 已註銷 | TFDA | |
| Taiwan | Hopan Tablets 0.5mg (Haloperidol) "Kojar" | 國嘉製藥工業股份有限公司幼獅三廠 | 錠劑 | Registered | TFDA | |
| Taiwan | Neusol Tablets 0.5mg (Haloperidol) "Bowlin" | 寶齡富錦製藥廠股份有限公司 | 錠劑 | 已註銷 | TFDA | |
| Argentina | Enabran | Casasco | 10 mg comp.x 60 | Listed | PAMI | |
| Argentina | Enabran | Casasco | 2 mg/ml gts.x 30 ml | Listed | PAMI | |
| Argentina | Haloperidol Denver Farma Decanoato | Denver Farma | 150 mg a.x 3 ml | Listed | PAMI | |
| Argentina | Haloperidol Medipharma | Medipharma | 10 mg comp.x 60 | Listed | PAMI | |
| Argentina | Haloperidol Medipharma | Medipharma | 5 mg comp.x 60 | Listed | PAMI | |
| Argentina | Haloperidol Medipharma | Medipharma | 5 mg comp.x 30 | Listed | PAMI | |
| Argentina | Haloperidol Medipharma | Medipharma | 10 mg comp.x 30 | Listed | PAMI | |
| Argentina | Haloperidol Vannier | Vannier | 10 mg comp.x 30 | Listed | PAMI | |
| Australia | Haldol decanoate | Ix | I.M. injection equivalent to 50 mg haloperidol in 1 mL ampoule | GE | PBS | |
| Australia | Haldol decanoate | Ix | I.M. injection equivalent to 150 mg haloperidol in 3 mL ampoule | GE | PBS | |
| Australia | Haloperidol Medsurge | Dz | Injection 5 mg in 1 mL | GE | PBS | |
| Australia | Haloperidol Medsurge | Dz | Injection 5 mg in 1 mL | DB | PBS | |
| Australia | Serenace | As | Oral solution 2 mg per mL, 100 mL | GE | PBS | |
| Australia | Serenace | As | Injection 5 mg in 1 mL | PL | PBS | |
| Australia | Serenace | As | Tablet 5 mg | GE | PBS | |
| Australia | Serenace | As | Tablet 500 micrograms | GE | PBS | |
| Austria | Haldol 1 mg Tabl. | — | 100St | green box | eEKO (Erstattungskodex) | |
| Austria | Haldol 1 mg Tabl. | — | 50St | green box | eEKO (Erstattungskodex) | |
| Austria | Haldol 10 mg Tabl. | — | 100St | green box | eEKO (Erstattungskodex) | |
| Austria | Haldol 10 mg Tabl. | — | 20St | green box | eEKO (Erstattungskodex) | |
| Austria | Haldol 2 mg/ml Tropf. zum Einnehmen, Lsg. | — | 30ml | green box | eEKO (Erstattungskodex) | |
| Austria | Haldol Decanoat 50 mg/ml Inj.lsg. (1 ml) | — | 1St | green box | eEKO (Erstattungskodex) | |
| Austria | Haldol Decanoat 50 mg/ml Inj.lsg. (3 ml) | — | 1St | green box | eEKO (Erstattungskodex) | |
| Bahrain | Halogol | Gulf Biotech Bsc (Closed), Bahrain. | 10 MG/2ML | Solution For Injection | POM | NHRA |
| Bolivia | Haloperidol | — | 5 mg/ml | Inyectable | LINAME (formulary) | |
| Bolivia | Haloperidol | — | 2 mg/ml | Solución oral | LINAME (formulary) | |
| Bolivia | Haloperidol | — | 5 mg | Comprimido | LINAME (formulary) | |
| Bolivia | Haloperidol decanoato | — | 50 mg/ml | Inyectable | LINAME (formulary) | |
| Brazil | Furp-Haloperidol | Fundação Para O Remédio Popular - Furp | 5 MG COM CX 25 BL AL PLAS TRANS X 20 | Similar | CMED | |
| Brazil | Haldol | Moksha8 Brasil Industria E Comercio De Medicamentos Ltda | 5 MG COM CT BL AL PLAS TRANS X 20 | Novo | CMED | |
| Brazil | Haldol | Moksha8 Brasil Industria E Comercio De Medicamentos Ltda | 2 MG/ML SOL GOT OR CT FR GOT PLAS OPC X 30 ML | Novo | CMED | |
| Brazil | Haldol | Janssen-Cilag Farmaceutica Ltda | 2 MG/ML SOL GOT OR CT FR GOT PLAS OPC X 30 ML | Novo | CMED | |
| Brazil | Haldol | Janssen-Cilag Farmaceutica Ltda | 5 MG COM CT BL AL PLAS TRANS X 20 | Novo | CMED | |
| Brazil | Haldol | Janssen-Cilag Farmaceutica Ltda | 1 MG COM CT BL AL PLAS TRANS X 20 | Novo | CMED | |
| Brazil | Haldol | Moksha8 Brasil Industria E Comercio De Medicamentos Ltda | 1 MG COM CT BL AL PLAS TRANS X 20 | Novo | CMED | |
| Brazil | Halo | Cristália Produtos Químicos Farmacêuticos Ltda. | 1 MG COM CX BL AL PLAS TRANS X 200 | Similar | CMED | |
| Bulgaria | Haloperidol - Richter | Gedeon Richter Plc. | 1,5 mg tablets | таблетка | По лекарско предписание | BDA |
| Bulgaria | Haloperidol Sopharma | Софарма Ад | 5 mg/ml solution for injection | инжекционен разтвор | По лекарско предписание | BDA |
| Croatia | haloperidol | — | oralne kapi | R | HZZO | |
| Croatia | Haloperidol depo Krka | KRKA-FARMA d.o.o. | otop. za inj. s prod. oslob., 5x50 mg/ml | HZZO | ||
| Croatia | Haloperidol Krka | KRKA-FARMA d.o.o. | tbl. 30x10 mg | R | HZZO | |
| Croatia | Haloperidol Krka | KRKA-FARMA d.o.o. | otop. za inj., 10x5 mg/ml | HZZO | ||
| Czech Republic | Haloperidol Sopharma | — | 5MG/ML | Inj Sol | F | SUKL DLP |
| Czech Republic | Haloperidol Wzf | — | 5MG/ML | Inj Sol | F | SUKL DLP |
| Czech Republic | Haloperidol-Richter | — | 1,5MG | Tbl Nob | R | SUKL DLP |
| Czech Republic | Haloperidol-Richter | — | 5MG/ML | Inj Sol | R | SUKL DLP |
| Czech Republic | Haloperidol-Richter | — | 2MG/ML | Por Gtt Sol | R | SUKL DLP |
| Denmark | Haloperidol "Orifarm" | Orifarm A/S | 100 mg/ml | injektionsvæske, opløsning | Par-Imp | Laegemiddelstyrelsen |
| Denmark | Serenase | Essential Pharma Limited | 5 mg/ml | injektionsvæske, opløsning | MRP | Laegemiddelstyrelsen |
| Denmark | Serenase | Essential Pharma Limited | 2 mg/ml | oral opløsning | MRP | Laegemiddelstyrelsen |
| Denmark | Serenase | Essential Pharma Limited | 5 mg | tabletter | MRP | Laegemiddelstyrelsen |
| Denmark | Serenase Dekanoat | Essential Pharma Limited | 100 mg/ml | injektionsvæske, opløsning | MRP | Laegemiddelstyrelsen |
| Denmark | Serenase Dekanoat | Essential Pharma Limited | 50 mg/ml | injektionsvæske, opløsning | MRP | Laegemiddelstyrelsen |
| Dominican Republic | Butinon | Laboratorios Cymacla, S.r.l | Registered | MISPAS | ||
| Dominican Republic | Butinon | Laboratorios Cymacla, S.r.l | Registered | MISPAS | ||
| Dominican Republic | Celecoxib - 200 mg- Inmenol200 | Inmenol Industrial Laboratorios, Srl | Registered | MISPAS | ||
| Dominican Republic | Feltram | Laboratorios Feltrex, S.a. | Registered | MISPAS | ||
| Dominican Republic | Feltram | Laboratorios Feltrex, S.a. | Registered | MISPAS | ||
| Dominican Republic | Funziona | Lab. Catedral De Scavone Hnos. S. A. Acceso Norte | Registered | MISPAS | ||
| Dominican Republic | Funziona | Lab. Catedral De Scavone Hnos. S. A. Acceso Norte | Registered | MISPAS | ||
| Dominican Republic | Haldol | Janssen-Cilag, S.a. De C.v., Mexico | Registered | MISPAS | ||
| Ecuador | Haloperidol 50 mg/mL Solucion Inyectable | Laboratorio Denver Farma S.a. | Haloperidol decanoato 50mg | Solucion Inyectable | VIGENTE | ARCSA registro sanitario |
| Ecuador | Haloperidol 50 mg/mL Solución Inyectable | Caplin Point Laboratories Ltd. | Haloperidol Decanoato 70.52 mg 1.4102 mg de Haloperidol decanoato equivale a 1 mg de Haloperidol anhidro | Solucion Inyectable | VIGENTE | ARCSA registro sanitario |
| Finland | Haloperin | Orion Corporation Orion Pharma | 100 mg/ml | depotinjektioneste | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Haloperin | Medipolar | 1 mg | tabletti | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Haloperin | Medipolar | 2 mg/ml | tipat | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Haloperin | Orion Corporation Orion Pharma | 10 mg | tabletti | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Haloperin | Medipolar | 5 mg/ml | injektioneste | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Haloperin | Orion Corporation Orion Pharma | 150 mg/ml | depotinjektioneste | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Haloperin | Medipolar | 4 mg | tabletti | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Greece | ALOPERIDIN DECANOAS INJ.SOL 50 MG/1ML AMP BTx 1 AMP x 1 ML | Essential Pharma Limited, Malta | reimbursed | MoH deltio timwn | ||
| Greece | ALOPERIDIN DECANOAS INJ.SOL 50 MG/1ML AMP BTx 1 AMP x 3 ML | Essential Pharma Limited, Malta | reimbursed | MoH deltio timwn | ||
| Greece | ALOPERIDIN INJ.SOL 5MG/1ML AMP BTx 5 AMPS x 1ML | Essential Pharma Limited, Malta | reimbursed | MoH deltio timwn | ||
| Greece | ALOPERIDIN ORAL.SOL 2MG/ML FL x 30ML | Essential Pharma Limited, Malta | reimbursed | MoH deltio timwn | ||
| Greece | ALOPERIDIN TABLET 10MG/TAB ΒΤx 20 (BLISTERS) | Essential Pharma Limited, Malta | reimbursed | MoH deltio timwn | ||
| Greece | ALOPERIDIN TABLET 1MG/TAB ΒΤx30 (BLISTERS) | Essential Pharma Limited, Malta | reimbursed | MoH deltio timwn | ||
| Greece | ALOPERIDIN TABLET 5MG/TAB ΒΤx20 (BLISTERS) | Essential Pharma Limited, Malta | reimbursed | MoH deltio timwn | ||
| Hong Kong | Anin Tablets 5mg | Welldone Pharmaceuticals Limited | Registered | DH Drug Office | ||
| Hong Kong | Binin-U Inj 5mg/mL | Wilcome Pharmaceutical Co Ltd | Registered | DH Drug Office | ||
| Hong Kong | Haldol Drops Oral 2mg/mL | Hind Wing Co Ltd | Registered | DH Drug Office | ||
| Hong Kong | Haloper Tablets 10mg | Sino Pacific Pharma Company Limited | Registered | DH Drug Office | ||
| Hong Kong | Haloper Tablets 5mg | Sino Pacific Pharma Company Limited | Registered | DH Drug Office | ||
| Hong Kong | Haloperidol Inj 5mg/mL | Amdipharm Mercury (Hong Kong) Limited | Registered | DH Drug Office | ||
| Hong Kong | Haloperidol Kern Pharma Oral Drops 2mg/mL | Hind Wing Co Ltd | Registered | DH Drug Office | ||
| Hong Kong | Haloperidol Solution For Injection 5mg/1ml | Sino-Asia Pharmaceutical Supplies Ltd | Registered | DH Drug Office | ||
| Hungary | Haloperidol-Richter 1,5 mg Tabletta | Richter Gedeon Vegyészeti Gyár Nyilvánosan Működő Részvénytársaság | 50x buborékcsomagolásban | NEAK PUPHA | ||
| Hungary | Haloperidol-Richter 5 mg/mL Oldatos Injekció | Richter Gedeon Vegyészeti Gyár Nyilvánosan Működő Részvénytársaság | 5x1ml ampulla | NEAK PUPHA | ||
| Iceland | Haldol | Distica - óskráð lyf | 2 mg/ml | mixtúra | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Haldol | Parlogis - óskráð lyf | 2 mg/ml | mixtúra | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Haldol | Essential Pharma Ltd. | 5 mg/ml | stl | 1 | Lyfjastofnun lyfjaverdskra |
| Iceland | Haldol | Essential Pharma Ltd. | 1 mg | töflur | 1 | Lyfjastofnun lyfjaverdskra |
| Iceland | Haldol Depot | Essential Pharma Ltd. | 100 mg/ml | stl | 1 | Lyfjastofnun lyfjaverdskra |
| Iceland | Haloperidol | Distica - óskráð lyf | 4 mg | töflur | 0 | Lyfjastofnun lyfjaverdskra |
| Ireland | Haldol Decanoate 100 mg/ml Solution for Injection | Essential Pharma Limited | Solution for injection | Marketed | HPRA | |
| Ireland | Haldol Decanoate 50 mg/ml Solution for Injection | Essential Pharma Limited | Solution for injection | Marketed | HPRA | |
| Ireland | Haloperidol 5mg/ml Solution for Injection | Mercury Pharmaceuticals (Ireland) Ltd | Solution for injection | Not marketed | HPRA | |
| Lebanon | Haloperidol | Mediphar Laboratories | 20mg | Tablet | A1 | MoPH |
| Lebanon | Haloperidol | Mediphar Laboratories | 2mg | Tablet | A1 | MoPH |
| Lebanon | Haloperidol | Mediphar Laboratories | 10mg | Tablet | A1 | MoPH |
| Lebanon | Haloperidol | Mediphar Laboratories | 5mg | Tablet | A1 | MoPH |
| Luxembourg | HALDOL CPR. 5 mg 1*25 CPR. | — | RR | CNS liste positive | ||
| Luxembourg | HALDOL DECANOAS SOL.INJ. 100 mg / 1 mL 1*1 ampoule 1 mL | — | RR | CNS liste positive | ||
| Luxembourg | HALDOL DECANOAS SOL.INJ. 50 mg / 1 mL 1*1 ampoule 1 mL | — | RR | CNS liste positive | ||
| Luxembourg | HALDOL DECANOAS SOL.INJ. 50 mg / 1 mL 1*1 ampoule 3 mL | — | RR | CNS liste positive | ||
| Luxembourg | HALDOL SOL.BUV.GTTES 2 mg / 1 mL 1*1 flacon (LDPE) 30 mL | — | RR | CNS liste positive | ||
| Luxembourg | HALDOL SOL.INJ. 5 mg / 1 mL 1*5 AMP. 1 ML | — | RR | CNS liste positive | ||
| MA | Haloperidol | — | 1 MG | Comprime | G | CNOPS liste des medicaments |
| MA | Haloperidol Pharma 5 | — | 2 MG | Solution Buvable | G | CNOPS liste des medicaments |
See every manufacturer of Haloperidol worldwide →
Regulator price references for Haloperidol
Published list or reimbursement prices for Haloperidol presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Australia | Serenace | Tablet 500 micrograms | 3.06 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Serenace | Tablet 5 mg | 3.27 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Serenace | Tablet 1.5 mg | 3.41 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Serenace | Oral solution 2 mg per mL, 100 mL | 9.78 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Serenace | Injection 5 mg in 1 mL | 10.42 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Serenace | Injection 5 mg in 1 mL | 10.42 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Serenace | Injection 5 mg in 1 mL | 10.42 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Haldol decanoate | I.M. injection equivalent to 50 mg haloperidol in 1 mL ampoule | 15.30 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Haldol decanoate | I.M. injection equivalent to 150 mg haloperidol in 3 mL ampoule | 30.68 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Austria | Haldol 1 mg Tabl. | 1mg | 50St | 4.10 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Haldol 2 mg/ml Tropf. zum Einnehmen, Lsg. | 30ml | 30ml | 5.65 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Haldol 1 mg Tabl. | 1mg | 100St | 7.60 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Haldol Decanoat 50 mg/ml Inj.lsg. (1 ml) | 50mg/1ml | 1St | 9.60 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Haldol 10 mg Tabl. | 10mg | 20St | 13.15 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Haldol Decanoat 50 mg/ml Inj.lsg. (3 ml) | 50mg/1ml | 1St | 22.80 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Haldol 10 mg Tabl. | 10mg | 100St | 56.85 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Bahrain | Halogol | 10mg/2ml | 10 X 2ML | 13.77 BHD | retail (max) | NHRA | 2026-09-01 |
| Brazil | Haloperidol | 2mg/1ml | 2 MG/ML SOL OR CT FR GOT PLAS PEBD OPC X 20 ML | 5.10 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Haldol | 1mg | 1 MG COM CT BL AL PLAS TRANS X 20 | 5.53 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Haldol | 1mg | 1 MG COM CT BL AL PLAS TRANS X 20 | 5.53 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Halo | 5mg | 5 MG COM CT BL AL PLAS TRANS X 20 | 5.65 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Haloperidol | 5mg | 5 MG COM CT BL AL PLAS TRANS X 20 | 6.89 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Haldol | 5mg | 5 MG COM CT BL AL PLAS TRANS X 20 | 10.60 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Haldol | 5mg | 5 MG COM CT BL AL PLAS TRANS X 20 | 10.60 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Haldol | 2mg/1ml | 2 MG/ML SOL GOT OR CT FR GOT PLAS OPC X 30 ML | 12.34 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Haldol | 2mg/1ml | 2 MG/ML SOL GOT OR CT FR GOT PLAS OPC X 30 ML | 12.34 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Haloperidol | 5mg/1ml | 5 MG/ML SOL INJ IM CX 5 AMP VD AMB X 1 ML | 19.03 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Halo | 1mg | 1 MG COM CX BL AL PLAS TRANS X 200 | 33.39 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Uni Haloper | 5mg | 5 MG COM CT BL AL PLAS PVC/PVDC TRANS X 200 | 45.78 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Halo | 5mg | 5 MG COM CT BL AL PLAS TRANS X 200 | 56.54 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Halo | 2mg/1ml | 2 MG/ML SOL GOT OR CX 10 FR GOT PLAS OPC X 20 ML | 57.14 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Furp-Haloperidol | 5mg | 5 MG COM CX 25 BL AL PLAS TRANS X 20 | 59.46 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Haloperidol | 5mg/1ml | 5 MG/ML SOL INJ IM CX 25 AMP VD AMB X 1 ML | 95.22 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Haloperidol | 5mg/1ml | 5 MG/ML SOL INJ CT 60 AMP VD AMB X 1 ML | 153.01 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Uni Haloper | 5mg/1ml | 5 MG/ML SOL INJ CX 50 AMP VD AMB X 1 ML (EMB HOSP) | 198.55 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Hyporidrol | 5mg/1ml | 5 MG/ML SOL INJ IM CX 50 AMP VD AMB X 1 ML | 198.55 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Halo | 5mg/1ml | 5 MG/ML SOL INJ IM CX 50 AMP VD AMB X 1 ML | 256.94 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Greece | ALOPERIDIN ORAL.SOL 2MG/ML FL x 30ML | 2mg/1ml | 1.31 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | ALOPERIDIN INJ.SOL 5MG/1ML AMP BTx 5 AMPS x 1ML | 5mg/1ml | 1.35 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | ALOPERIDIN TABLET 1MG/TAB ΒΤx30 (BLISTERS) | 1mg | 1.44 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | ALOPERIDIN TABLET 5MG/TAB ΒΤx20 (BLISTERS) | 5mg | 2.89 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | ALOPERIDIN DECANOAS INJ.SOL 50 MG/1ML AMP BTx 1 AMP x 1 ML | 50mg/1ml | 3.72 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | ALOPERIDIN DECANOAS INJ.SOL 50 MG/1ML AMP BTx 1 AMP x 3 ML | 50mg/1ml | 5.32 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | ALOPERIDIN TABLET 10MG/TAB ΒΤx 20 (BLISTERS) | 10mg | 8.54 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Hungary | Haloperidol-Richter 1,5 mg Tabletta | 1.5mg | 50x buborékcsomagolásban | 677.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Haloperidol-Richter 5 mg/mL Oldatos Injekció | 1ml | 5x1ml ampulla | 767.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Iceland | Haldol | 5mg/1ml | lykjur | 343.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Haldol | 1mg | þpakki | 587.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Haldol | 2mg/1ml | fl | 1,520.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Haloperidol | 4mg | þpakki | 2,051.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Haldol | 2mg/1ml | fl | 2,730.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Haldol Depot | 100mg/1ml | lykjur | 5,718.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Lebanon | Haloperidol | 2mg | 30 | 2.82 USD | public price (USD, Decision 119/1) | MoPH | 2026-09-02 |
| Lebanon | Haloperidol | 5mg | 30 | 3.09 USD | public price (USD, Decision 119/1) | MoPH | 2026-09-02 |
| Lebanon | Haloperidol | 20mg | 30 | 3.79 USD | public price (USD, Decision 119/1) | MoPH | 2026-09-02 |
| Lebanon | Haloperidol | 10mg | 30 | 3.79 USD | public price (USD, Decision 119/1) | MoPH | 2026-09-02 |
| Luxembourg | HALDOL SOL.BUV.GTTES 2 mg / 1 mL 1*1 flacon (LDPE) 30 mL | 2mg/1ml | 7.67 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | HALDOL SOL.INJ. 5 mg / 1 mL 1*5 AMP. 1 ML | 5mg/1ml | 8.03 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | HALDOL CPR. 5 mg 1*25 CPR. | 5mg | 10.92 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | HALDOL DECANOAS SOL.INJ. 50 mg / 1 mL 1*1 ampoule 1 mL | 50mg/1ml | 11.52 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | HALDOL DECANOAS SOL.INJ. 100 mg / 1 mL 1*1 ampoule 1 mL | 100mg/1ml | 15.48 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | HALDOL DECANOAS SOL.INJ. 50 mg / 1 mL 1*1 ampoule 3 mL | 50mg/1ml | 21.12 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| MA | Haloperidol Pharma 5 | 2mg | 1 FLACON 15 ML | 13.20 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Haldol Fort | 2mg | 1 FLACON 15 ML | 13.80 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Haloperidol | 1mg | 1 BOITE 40 COMPRIME | 18.30 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| MA | Haloperidol | 5mg | 1 BOITE 5 AMPOULE INJECTABLE | 20.50 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
| Norway | Haldol | 5mg/1ml | 1 ml | 80.00 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Norway | Haldol | 1mg | 100 stk | 97.60 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Norway | Haldol Depot | 100mg/1ml | 1 ml | 540.00 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Saudi Arabia | Haldol 2mg-mL Drops | 2mg | 11.45 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Serenace | 16.45 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Haldol 5mg Tablet | 5mg | 19.75 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Haldol Decanoas Inj 50mg | 50mg | 21.85 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Haloperidol ALH | 21.85 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Haldol 5mg-mL Amp | 5mg | 23.15 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Zymar 0.3% Ophthalmic Solution | 0.5mg | 28.35 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Haldol Decanoas Inj 100mg-mL | 100mg | 41.35 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Serenace | 43.00 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Serenace | 57.35 SAR | public | SFDA | 2026-09-01 | ||
| Slovakia | Haloperidol-Richter 1,5 mg | 1.5mg | tbl 50x1,5 mg (blis.Al/PVC) | 1.84 EUR | categorised final price | MZ SR kategorizacia | 2026-09-02 |
Marketed Canadian products with the same active ingredient
| DIN | Product | Company | Strength | Form |
|---|---|---|---|---|
| 00808652 | Haloperidol Inj 5mg/mL USP | Sandoz Canada Incorporated | 5 mg | Liquid |
| 02366010 | Haloperidol Injection | Juno Pharma Canada Inc. | 5 mg | Solution |
| 00713449 | Teva-Haloperidol | Teva Canada Limited | 10 mg | Tablet |
| 00363650 | Teva-Haloperidol | Teva Canada Limited | 5 mg | Tablet |
| 00363669 | Teva-Haloperidol | Teva Canada Limited | 2 mg | Tablet |
| 00363677 | Teva-Haloperidol | Teva Canada Limited | 1 mg | Tablet |
| 00363685 | Teva-Haloperidol | Teva Canada Limited | 0.5 mg | Tablet |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Nu-Haloperidol (DIN 02239216) marketed in Canada?
No. Health Canada lists DIN 02239216 as Cancelled (Unreturned Annual) as of 28 Mar 2018.
Who holds the Canadian licence for this product?
Nu-Pharm Inc is the company of record in the Health Canada Drug Product Database.
Is Haloperidol registered outside Canada?
Yes — Nexara Health has matched 721 registrations in 38 other markets, including 12 in the same strength and dosage form (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02239216, status date 2018-03-28; national medicine registries: ANMDMR nomenclator, ARCSA registro sanitario, BDA, CMED, CNOPS liste des medicaments, CNS liste positive, DH Drug Office, eEKO (Erstattungskodex), Fimea Perusrekisteri, HPRA, HZZO, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, MoPH, NEAK PUPHA, NHRA, PAMI, PBS, SUKL DLP, TFDA; price sources: CMED, CNOPS liste des medicaments, CNS liste positive, DMP (Statens legemiddelverk) maksimalpris, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MoPH, MZ SR kategorizacia, NEAK PUPHA, NHRA, PBS, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02239216, status date 2018-03-28; national medicine registries: ANMDMR nomenclator, ARCSA registro sanitario, BDA, CMED, CNOPS liste des medicaments, CNS liste positive, DH Drug Office, eEKO (Erstattungskodex), Fimea Perusrekisteri, HPRA, HZZO, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, MoPH, NEAK PUPHA, NHRA, PAMI, PBS, SUKL DLP, TFDA; price sources: CMED, CNOPS liste des medicaments, CNS liste positive, DMP (Statens legemiddelverk) maksimalpris, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MoPH, MZ SR kategorizacia, NEAK PUPHA, NHRA, PBS, SFDA.
Nu-Pharm Inc — company profileWho else makes HaloperidolAll Canadian Haloperidol productsHaloperidol Inj 5mg/mL USPHaloperidol InjectionTeva-HaloperidolTeva-HaloperidolTeva-Haloperidol
Health Canada Drug Product Database (DPD), DIN 02239216, status date 2018-03-28; national medicine registries: ANMDMR nomenclator, ARCSA registro sanitario, BDA, CMED, CNOPS liste des medicaments, CNS liste positive, DH Drug Office, eEKO (Erstattungskodex), Fimea Perusrekisteri, HPRA, HZZO, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, MoPH, NEAK PUPHA, NHRA, PAMI, PBS, SUKL DLP, TFDA; price sources: CMED, CNOPS liste des medicaments, CNS liste positive, DMP (Statens legemiddelverk) maksimalpris, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MoPH, MZ SR kategorizacia, NEAK PUPHA, NHRA, PBS, SFDA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.